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Abstract
Aims—Determine if parental diabetes(DM) is associated with unhealthier cardiovascular 
disease(CVD) risk profiles in youth with type 2 diabetes(T2D), and whether associations differed 
by race/ethnicity.
Methods—Family history was available for 382 youth with T2D from 2001 prevalent and 2002–
2005 incident SEARCH for Diabetes in Youth cohorts.
Parental DM was evaluated two ways—two-category— any parent vs. no parent DM 
(evaluated overall and stratified by race/ethnicity); four-category— both parents, mother only, 
father only, or no parent DM (evaluated overall only). Associations with hemoglobin 
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A1c(HbA1c), fasting lipids, blood pressure(BP), and urine albumin:creatinine ratio(ACR) were 
examined using regression models.
Results—Overall, sample characteristics included: 35.9% male, 19.1% non-Hispanic 
white(NHW), mean T2D duration 26.6 ± 22.2 months, mean HbA1c 7.9 ± 2.5% (62.6 ± 
27.8mmol/mol). Unadjusted two-category comparisons showed youth with parental DM had 
higher HbA1c, higher DBP, and higher frequency of elevated ACR. Adjusted two-category 
comparisons showed associations remaining in non-stratified analysis for ACR 
[OR95%CI)=2.3(1.1, 5.0)] and in NHW youth for HbA1c [6.8% ± 0.4 v. 8.0 ± 0.4 
(51.1±4.8mmol/mol v.63.9 ± 4.2), p=.015], DBP (67.7% ± 4.5 v. 76.9 ± 4.4 mmHg, p=.014) and 
lnTG (4.7±0.3 v. 5.3±0.3, p=.008). There were no significant findings in the adjusted four-
category evaluation.
Conclusions—Parental history of diabetes may be associated with unhealthier CVD risk factors 
in youth with T2D.
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1. Introduction
Cardiovascular disease (CVD) is an established macrovascular complication of type 2 
diabetes (T2D), and individuals with T2D are known to be at an increased risk for early 
onset of CVD. Adults with any type of diabetes have death rates from CVD 1.7 times higher 
than adults who do not have diabetes (1). In adults aged 65 years and older with diabetes-
related causes of death, 68% of death certificates also cite heart disease and 16% also cite 
stroke as causes of death (2). These problems are magnified in the population by the 
increasing incidence of T2D (3). Additionally, it is well-known that atherosclerosis emerges 
during childhood (4–5). Therefore, the estimated 5,100 youth who are diagnosed with T2D 
each year in the United States may be at a higher risk for cardiovascular morbidity and 
mortality because of the early onset and longer duration of T2D as they enter adulthood (6). 
The SEARCH for Diabetes in Youth Study (SEARCH) has shown that youth with T2D have 
more arterial stiffness than youth with type 1 diabetes (T1D), while the TODAY study has 
shown that over a 3 year period, the number of youth with T2D meeting recommended 
thresholds for treatment with lipid-lowering medication treatment tripled (7–8).
Familial clustering of cardiovascular disease risk factors such as T2D, hypertension, 
hypercholesterolemia, and hyperalbuminuria is well-known. Certainly, shared lifestyles are 
involved in the pathophysiology of the development of these disorders; however, family and 
twin studies also suggest underlying genetic and epigenetic influences (9–15). Additionally, 
CVD risk factors have been shown to differ by ethnicity (16). Considering the interplay of 
genetic background and epigenetic and lifestyle influences, it is plausible that the 
relationship between family history of diabetes and the risk for CVD in offspring may differ 
for individuals of varying racial or ethnic backgrounds.
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Therefore, the goal of this study was to explore the association between parental diabetes 
and the CVD risk profiles of youth with T2D enrolled in the SEARCH study. The secondary 
goal of this study was to examine whether the association between parental history and CVD 
risk profile also differed by race or ethnicity. We hypothesized that unhealthier CVD risk 
factors [as assessed by higher levels of HbA1c, higher blood pressure (BP), higher fasting 
total cholesterol (TC), higher fasting low density lipoprotein (LDL), higher fasting 
triglycerides (TG), lower fasting high density lipoprotein (HDL), higher apolipoprotein B 
(apoB), and higher urine albumin to creatinine ratio (ACR)] would be most likely present in 
the offspring of two parents with diabetes and the most favorable profile would be seen in 
those without a parental history of diabetes. Among youth with T2D with at least one parent 
with diabetes, we hypothesized that those with a mother with diabetes would have a more 
adverse CVD risk profile than those with a father with diabetes due to the additional 
contribution of possible intrauterine exposure.
2. Subjects, Materials, and Methods
Data for these analyses were collected as part of the SEARCH study protocol. A detailed 
description of the SEARCH study methods has been published elsewhere(17). Briefly, 
SEARCH has been conducting population-based case ascertainment of youth < 20 years old 
with prevalent diabetes in 2001 and 2009 and newly diagnosed (incident) diabetes starting in 
2002 and continuing through the present. SEARCH recruited participants from four 
geographically defined populations in Ohio, Colorado, South Carolina and Washington, as 
well as from Indian Health Service beneficiary roles of several American Indian 
populations, and among enrollees in a managed health care plan in California. Participants 
were invited to participate in a research visit, during which fasting blood samples were 
obtained if metabolically stable (defined as no episode of diabetic ketoacidosis during the 
previous month), physical measurements were taken, and questionnaires were administered. 
The study was reviewed and approved by the local Institutional Review Board(s) that had 
jurisdiction over the local study population and all participants provided informed consent 
and/or assent.
2.1. Measurements
Study visits occurred after an eight hour overnight fast. Participants did not take diabetes 
medications the morning of the visit. Participants on long-acting insulin took it the evening 
before the visit and then it was withheld. A brief physical examination was conducted 
including measurement of BP, weight, and height using standardized procedures. Body mass 
index was calculated (BMI [kg/m2]), and age- and sex-specific BMI z-scores were 
calculated using growth charts with a SAS program available from the Centers for Disease 
Control and Prevention(18). Waist circumference was measured using NHANES III 
protocol(19). Waist z-scores were calculated by age and gender from CDC growth reference 
year 2000. Race and ethnicity were self-reported using 2000 United States Census 
questions(20) and classified as Hispanic, non- Hispanic White(NHW), non-Hispanic 
Black(NHB), American Indian(AI), and Asian/Pacific Islander(API). For these analyses, 
race or ethnicity was categorized as NHB, Hispanic, NHW, and combined API/AI. API and 
AI were combined to create a category of comparable size to the other categories and also of 
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sufficient size for analysis. Family history of diabetes was collected by questionnaire; 
however, information on type of parental diabetes was not collected. History of parental 
diabetes at any time point (regardless of timing with offspring’s birth or diagnosis) was 
classified as a positive parental history in these analyses.
Fasting blood samples were used to analyze diabetes autoantibodies (DAA), HbA1c and 
lipids (TC, TG, HDL, LDL, and apoB). Spot urine samples were used to measure ACR. 
Assays were performed at the Northwest Lipid Metabolism and Diabetes Research 
Laboratories, University of Washington. Glutamic acid decarboxylase-65 (GAD65) and 
insulinoma-associated-2 (IA-2A) autoantibodies were analyzed using a standardized 
protocol and a common serum calibrator developed by the National Institute of Diabetes and 
Digestive and Kidney Diseases (NIDDK) sponsored standardization group(21). The cutoff 
values for positivity were 33 NIDDKU/ml for GAD65 and 5 NIDDKU/ml for IA-2A. 
HbA1c(%) was measured in whole blood with an automated nonporous ion-exchange high-
performance liquid chromatography system(model G-7; Tosoh Bioscience, 
Montgomeryville, Pennsylvania).
2.2. Study Participants
Inclusion criteria for this report include all youth aged < 20 years whose diabetes was 
prevalent in 2001 or newly diagnosed in 2002–2005, with T2D as diagnosed by their health 
care provider and who had a SEARCH study visit (n=581). From the 581 individuals, we 
hierarchically excluded those with positive DAA (n=42), time from diagnosis to initial study 
visit was less than 3 months to allow for some stabilization of glycemic control which could 
otherwise negatively impact outcome measures (n=26), history of steroid use or diagnosis of 
other medical conditions frequently treated with steroids (n=9), missing information for race 
or ethnicity (n=4), missing information on all outcomes of interest (n=45), and those for 
whom we were unable to determine that at least 1 parent had diabetes or both parents did not 
have diabetes (n=73). For the four category exposure analysis, we excluded an additional 20 
individuals for whom diabetes status could not be determined for both parents.
2.3. Statistical Analysis
Participant characteristics were described using means(SD) or proportions(%). Comparisons 
across parental diabetes groups were examined using chi square or Fisher’s exact test, as 
well as simple and multivariable logistic regression models (categorical outcomes), or 
simple and multivariable linear regression models (continuous outcomes). Natural log 
transformation was applied to the triglyceride variable before analysis due to skewed 
distribution.
Parental diabetes exposure groups were divided both into 2 categories [parental history of 
diabetes in either or both parents (parental DM) and no parental history of diabetes(no 
parental DM)] and 4 categories [both parents with history of diabetes(both parents DM), 
maternal history of diabetes only(maternal DM), paternal history of diabetes only(paternal 
DM), and no parental history of diabetes(no parental DM)]. The 2 category exposure 
definition was examined overall and stratified by the 4 race or ethnicity groups (NHB, 
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Hispanic, NHW, and API/AI), however the 4 category exposure definition was not stratified 
by race or ethnicity because of sample size limitations.
Modeling was conducted using sequential models with groups of covariates added to 
subsequent models culminating in the maximally adjusted model. Model covariates 
included: gender, clinic, highest parental education, smoking status, physical activity level, 
BMI z-score, waist z-score, time since diagnosis, age at diagnosis, insulin use, hypertensive 
medication use (blood pressure and ACR outcomes only), and lipid medication use (lipid 
outcomes only). In these descriptive analyses, we chose not to adjust for multiple 
comparisons, although by testing several variables in the present study, we may have 
increased the likelihood of uncovering spurious associations that would need verification in 
other populations.
All statistical comparisons were conducted using SAS version 9.3 (SAS Institute, Cary, NC, 
USA). Results were considered significant if p < 0.05.
3. Results
Overall, 382 participants were included in the two category analysis of parental diabetes, 
and 362 participants were included in the four category analysis of parental diabetes (Table 
1). Participants in the two category analysis were diagnosed with T2D at a mean age of 13.8 
± 2.5 years, had been diagnosed for a mean of 26.6 ± 22.2 months at the time of their study 
visit, were predominantly of non-white racial or ethnic groups (38.2% NHB, 23.0% 
Hispanic, 19.6% API/AI), and had a mean BMI z-score at SEARCH visit of 2.1 ± 0.7. There 
were no differences between categories of parental diabetes for these participant 
characteristics in the two-category analysis. Participant characteristics were similar for those 
participants included in the four-category analysis with the exception of duration of diabetes 
at time of SEARCH visit. The duration of T2D in the four-category analysis varied 
significantly from 23.5 ± 20.8 months for those with no parental diabetes to 34.8 ± 25.5 for 
those with both parents having a diagnosis of diabetes (p=0.009).
Unadjusted comparison of CVD risk profile outcomes by the two categories of parental 
history of diabetes revealed that participants with a parental history of diabetes overall had 
significantly higher HbA1c [8.1% ± 2.5 v. 7.4 ± 2.6 (65.4mmol/mol ± 27.3 v. 57.2 ± 28.2), 
p=0.008], higher DBP (74.3 mmHg ± 10.4 v. 71.7 ± 10.8, p=0.025), and higher percentage 
with elevated ACR [25.9% v. 15.5, OR95% CI) 1.9(1.02, 3.52), p=0.043] than those in the 
no parental diabetes group (Table 1). However, none of these relationships except elevated 
ACR were significant after initial adjustments for confounders (Table 2). In the models 
stratified by race or ethnicity, significantly higher HbA1c, DBP, and lnTG remained after 
adjustment in the NHW group with parental diabetes compared to the NHW group without 
parental diabetes [HbA1c 8.0% ± 0.4 v. 6.8 ± 0.4 (63.9 mmol/mol ± 4.2 v. 51.1 ± 4.8), 
p=0.015; DBP 76.9 mmHg ± 4.4 v. 67.7 ±4.5, p=0.014; and lnTG 5.3 ± 0.3 v. 4.7 ±0.3, 
p=0.008]. However, none of the other race or ethnic group-related models demonstrated 
significant associations between CVD risk factors and parental history of diabetes (data not 
shown). Interaction of race or ethnicity groups with the two-category exposure on CVD risk 
factors was only statistically significant for DBP (p=0.048).
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Unadjusted four category comparison of CVD risk profile outcomes (Table 1) revealed 
significant differences in HbA1c levels (p=0.047) such that the highest HbA1c was in the 
group with both parents with diabetes (8.5% ± 2.5, 68.9 mmol/mol ± 27.7) followed by 
those with a father with diabetes (8.1% ± 2.6, 65.0 mmol/mol ± 28.5), a mother with 
diabetes (8.0% ± 2.5, 63.9 mmol/mol ± 27.3), and no parent with diabetes (7.4% ± 2.6, 57.2 
mmol/mol ± 28.2) [p=0.01 for both parents v. no parent with diabetes]. Differences were no 
longer significant when controlled for demographic and health behavior variables (data not 
shown).
4. Discussion
Our unadjusted findings suggest that among the total sample of youth with T2D, a parental 
history of diabetes is associated with higher HbA1c, higher DBP, and higher odds of 
elevated ACR, and the association with ACR remained after adjustment. Among the NHW 
youth, all models showed HbA1c and DBP to be significantly associated with parental 
diabetes, and lnTG emerged as significantly associated. No significant associations were 
observed among the other three race or ethnic groups studied.
Our study furthers previous work in SEARCH examining the influence of parental diabetes 
on characteristics of youth with T2D, including the finding that youth with T2D who are 
exposed to diabetes in utero are diagnosed at a younger age and that history of maternal 
diabetes and obesity during pregnancy accounts for 47.2% of T2D in youth (22–23). 
SEARCH has also previously shown that children with T2D who have a family history of 
diabetes onset after age 25 had more atherogenic lipid profiles, higher blood pressures, 
larger waist circumferences, and higher BMI z-scores (24). However, in this earlier 
SEARCH phase, siblings and grandparents were included along with the parents and not 
differentiated from the parents in the analysis.
Previous studies report from various populations that both support and contradict our 
findings. The Bogalusa Heart Study showed that young adults without diabetes who are 
offspring of parents with diabetes are more likely to be hypertensive and have higher TG 
levels, lower HDL, and higher LDL levels, and longitudinal changes in risk markers did not 
differ by race (25). Altinli et al. reported increased SBP in offspring of parents with diabetes 
but no difference in DBP or lipid levels in a Turkish population (26). A systematic review 
and meta-analysis examining blood pressure in offspring of mothers with diabetes also 
found only increased SBP (27). However, several other studies from the Netherlands, 
Germany, India, and the United States have not found associations over time between 
parental history of diabetes, metabolic syndrome, or gestational diabetes with offspring 
lipid, blood pressure, or HbA1c measurements (28– 31). Pima Indian adults with T2D who 
are offspring of mothers with T2D have been shown to have higher odds of 
microalbuminuria, though family history of diabetes was not shown to be associated with 
microalbuminuria in Swedish youth with insulindependent diabetes (32, 10). The finding of 
a larger proportion with microalbuminuria and higher DBP among offspring of parents with 
T2D is alarming considering that these markers independently increase the risk of mortality 
in people with young-onset T2D (33).
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The present study did not directly compare the CVD risk profiles between race or ethnic 
groups, and prior studies conflict regarding whether NHW individuals are more likely to 
have CVD risk factors compared to individuals of other race or ethnic groups. For example, 
SEARCH has previously shown that hypertension disproportionately affects minority race 
or ethnic youth with either T1D or T2D compared to NHW youth (34), while the TODAY 
study has reported a higher prevalence of hypertension in NHW youth with T2D than NHB 
and Hispanic youth (35), and a systematic review showed NHW adults with either T1D or 
T2D have a higher risk for CVD complications than NHB, Hispanic Americans, and Asian 
Americans (36). Therefore, it is possible that the higher HbA1c, DBP, and lnTG that the 
present study found in the NHW group with a parental history of diabetes may compound an 
underlying higher risk for CVD in NHW youth with T2D.
One of the great strengths of SEARCH is that its cohort derives from a diverse racial and 
ethnic population. A limitation for the present study is that current SEARCH data do not 
differentiate between types of parental diabetes (eg, T1D, T2D, gestational, or MODY). 
Therefore, further associations between the particular type of parental diabetes and the 
offspring’s CVD risk factors may be found if this information were available. An additional 
limitation of the present study is the use of a single random urine specimen. Intraindividual 
variation in ACR and orthostatic proteinuria are common in adolescents (37, 38). However, 
both situations would bias the results toward the null hypothesis due to nondifferential 
misclassification.
Exploring the association between parental diabetes and the CVD risk factors of offspring is 
difficult due to the insidious nature of T2D onset in many people. However, this work and 
many of the studies cited herein support a contribution of parental diabetes to adverse CVD 
risk factors in offspring. Given the known risk of premature CVD morbidity and mortality in 
adults with T2D and the rising incidence of T2D in youth, further work is required in youth 
with T2D to define both the contribution of parental diabetes to CVD risk in offspring and 
interventions to limit CVD risk.
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